USPTO serial 79325184
NEURAMEDY
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 25, 2023
- Examiner
- GILBERT, REBECCA L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with NEURAMEDY?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Cindy L. Caditz
Cindy L. Caditz Davis Wright Tremaine LLP920 Fifth Avenue, Suite 3300Seattle, WA 98104UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Medicines for human purposes for the treatment of Central Nervous System (CNS) diseases; cardiovascular pharmaceutical preparations; pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations for the prevention of diseases of the cardio-vascular system; ophthalmic preparations; allergy medications; pharmaceutical preparations for diagnosis of Central Nervous System (CNS) diseases; pharmaceutical preparations and substances with analgesic properties; ethical medicinal preparations for the treatment of Central Nervous System (CNS) diseases; therapeutic drugs and therapeutic agents for treating Central Nervous System (CNS) diseases; pharmaceutical preparations for the treatment of Parkinson's disease; plant extracts for pharmaceutical purposes; medicated lozenges for pharmaceutical purposes; pharmaceutical preparations for use in dermatology; ferments for pharmaceutical purposes; pharmaceutical agents affecting sensory organs; drugs for medical purposes for the treatment of Central Nervous System (CNS) diseases; pharmaceutical preparations for the treatment of Central Nervous System (CNS) diseases | ACTIVE | — |
| 042 | Research and development of vaccines and medicines; medical research in the field of crude drugs; conducting early evaluations in the field of new pharmaceuticals; drug discovery services; development of pharmaceutical preparations and medicines; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical research services; medical and scientific research, namely, clinical testing of medicines; pharmaceutical drug development services; consultancy pertaining to pharmacology; testing of pharmaceuticals; pharmaceutical product evaluation; medical laboratory services; scientific research services for medical purposes; scientific research in the field of medicine; scientific analysis and evaluation of medical product development; medical and pharmacological research services; scientific research in the fields of medicine/health and pharmacology; scientific research in the nature of conducting clinical trials for others; development of medical products | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Neuramedy Co., Ltd.
- Other trademarks owned by Neuramedy Co., Ltd.
- Other trademarks owned by Neuramedy Co., Ltd.
- Other trademarks in Class 005
- Other trademarks in Class 042
- Similar marks named NEURAMEDY
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 25, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Aug 28, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Aug 3, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Aug 3, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jul 25, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jun 30, 2023 | EWAF | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS | — |
| Jun 30, 2023 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Jun 30, 2023 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jun 30, 2023 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| May 1, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 25, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 25, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 12, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 12, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Feb 7, 2023 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Feb 7, 2023 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Feb 7, 2023 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 18, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 18, 2023 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jan 18, 2023 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jan 5, 2023 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jan 5, 2023 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jan 5, 2023 | ALIE | ASSIGNED TO LIE | — |
| Jan 4, 2023 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jan 4, 2023 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jan 4, 2023 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 21, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 20, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 20, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 23, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Aug 2, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Aug 2, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 13, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 12, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 12, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 16, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 12, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 11, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |